Hepatitis in Human Immunodeficiency Virus Coinfection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-07-21
Clinical Trial Update: An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients [Phase 3]
Phase III open-label trial comparing Algeron (cepeginterferon alfa-2b) with PegIntron (peginterferon alfa-2b) plus ribavirin in HIV-coinfect…